Menu
中文Book a checkup
Shin Kong Wu Ho-Su Memorial Hospital Health Management Center · Taipei · Medical center

Women's Checkup

US$1,016
NT$32,600 · you pay the hospital in NT$
Book this checkup

Prefer to book it yourself? Call Shin Kong Wu Ho-Su Memorial Hospital on (02)2833-2211 or use its website ↗. It's free; most hospitals take bookings in Chinese.

We book it with the hospital for you, from US$149, paid only after the hospital confirms. We reply by email with available dates, the confirmed price, and whether an English report is available.

Paying from a US account? HSA and FSA notes.

Share on LINE / 分享到 LINE

As published by the hospital · checked 2026-09-22

A premium-tier program with Colonoscopy, Gastroscopy (upper GI endoscopy), Abdominal ultrasound, Breast ultrasound and Pelvic (gynecologic) ultrasound and a 53-test panel.

Sedation
Available
English report
Ask the hospital (we ask for you in Book it for me)

What stands out

Colonoscopy

Colon polyps and colorectal cancer; polyps can usually be removed during the same exam.

Gastroscopy (upper GI endoscopy)

Stomach and esophagus ulcers, inflammation and cancer.

Abdominal ultrasound

Liver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.

Breast ultrasound

Breast lumps; complements mammography, especially in dense breasts.

Every test, in English

53 tests listed, 45 of them on our shared test list, so they line up against other hospitals' packages.

Vitals3
Blood Count2
Liver Function7
Kidney & Electrolytes4
Lipids & Cardiometabolic3
Glucose2
Thyroid & Endocrine2
Tumor Markers6
Infection Serology3
Cardiac1
X-ray2
Ultrasound3
Endoscopy2
Women's Health3
Bone & Body Composition1
ENT & Dental1
Show all 53 tests and what each screens for
TestScreens forAdd-on?
Vitals
Blood pressureScreens for hypertension, a major risk factor for heart disease and stroke.Incl.
Height, weight and BMIBasic body measurements used to assess weight-related health risk.Incl.
Basic vital signs (pulse, temperature, respiration)Basic pulse, temperature and breathing rate measurements taken during a checkup.Incl.
Blood Count
Complete blood countAnemia, infection and blood cell disorders.Incl.
White blood cell differentialBreakdown of white cell types; infection, allergy and some blood cancers.Incl.
Liver Function
AlbuminLiver function and nutrition status.Incl.
Alkaline phosphataseLiver, bile duct and bone conditions.Incl.
ALT (SGPT)Liver cell damage; the most common liver screening test.Incl.
AST (SGOT)Liver cell damage.Incl.
Direct bilirubinBile duct obstruction.Incl.
Gamma-GTBile duct and alcohol-related liver stress.Incl.
Total bilirubinJaundice, liver and bile problems.Incl.
Kidney & Electrolytes
Blood urea nitrogenKidney function.Incl.
CreatinineKidney function.Incl.
Electrolytes (Na, K, Cl)Salt and fluid balance; kidney and hormone problems.Incl.
Uric acidGout risk and kidney stone risk.Incl.
Lipids & Cardiometabolic
HDL cholesterolProtective cholesterol level.Incl.
LDL cholesterolThe main cholesterol driving heart disease risk.Incl.
Total cholesterolCardiovascular risk.Incl.
Glucose
Fasting glucoseDiabetes and prediabetes.Incl.
Hemoglobin A1cAverage blood sugar over the past three months; diabetes.Incl.
Thyroid & Endocrine
TSHThyroid function; the primary thyroid screening test.Incl.
Vitamin D (25-OH)Vitamin D deficiency; bone health.Incl.
Tumor Markers
AFPLiver cancer marker (also used with liver ultrasound in hepatitis B carriers).Incl.
CA-125Ovarian cancer marker.Incl.
CA 15-3Breast cancer marker.Incl.
CA 19-9Pancreatic and biliary cancer marker.Incl.
CEAColorectal and other GI cancer marker.Incl.
PSAProstate cancer marker.Incl.
Infection Serology
Hepatitis B surface antibodyImmunity to hepatitis B (from vaccine or past infection).Incl.
Hepatitis C antibodyHepatitis C infection.Incl.
Hepatitis B surface antigenCurrent hepatitis B infection; very common in Taiwan.Incl.
Cardiac
Resting ECGHeart rhythm and signs of prior heart damage.Incl.
X-ray
Abdominal X-ray (KUB)Kidney stones and bowel abnormalities.Incl.
Chest X-rayLung, heart size and chest abnormalities.Incl.
Ultrasound
Abdominal ultrasoundLiver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.Incl.
Breast ultrasoundBreast lumps; complements mammography, especially in dense breasts.Incl.
Pelvic (gynecologic) ultrasoundUterus and ovary abnormalities (fibroids, cysts).Incl.
Endoscopy
ColonoscopyColon polyps and colorectal cancer; polyps can usually be removed during the same exam.Incl.
Gastroscopy (upper GI endoscopy)Stomach and esophagus ulcers, inflammation and cancer.Incl.
Women's Health
HPV DNA testHigh-risk HPV strains that cause cervical cancer.Incl.
MammographyBreast cancer; the standard screen for women 40+.Add-on
Pap smearCervical cancer and precancer.Incl.
Bone & Body Composition
Bone density (DXA)Osteoporosis and fracture risk.Add-on
ENT & Dental
ENT examinationEar, nose and throat abnormalities.Incl.
Vitals
Blood pressureIncl.
Screens for hypertension, a major risk factor for heart disease and stroke.
Height, weight and BMIIncl.
Basic body measurements used to assess weight-related health risk.
Basic vital signs (pulse, temperature, respiration)Incl.
Basic pulse, temperature and breathing rate measurements taken during a checkup.
Blood Count
Complete blood countIncl.
Anemia, infection and blood cell disorders.
White blood cell differentialIncl.
Breakdown of white cell types; infection, allergy and some blood cancers.
Liver Function
AlbuminIncl.
Liver function and nutrition status.
Alkaline phosphataseIncl.
Liver, bile duct and bone conditions.
ALT (SGPT)Incl.
Liver cell damage; the most common liver screening test.
AST (SGOT)Incl.
Liver cell damage.
Direct bilirubinIncl.
Bile duct obstruction.
Gamma-GTIncl.
Bile duct and alcohol-related liver stress.
Total bilirubinIncl.
Jaundice, liver and bile problems.
Kidney & Electrolytes
Blood urea nitrogenIncl.
Kidney function.
CreatinineIncl.
Kidney function.
Electrolytes (Na, K, Cl)Incl.
Salt and fluid balance; kidney and hormone problems.
Uric acidIncl.
Gout risk and kidney stone risk.
Lipids & Cardiometabolic
HDL cholesterolIncl.
Protective cholesterol level.
LDL cholesterolIncl.
The main cholesterol driving heart disease risk.
Total cholesterolIncl.
Cardiovascular risk.
Glucose
Fasting glucoseIncl.
Diabetes and prediabetes.
Hemoglobin A1cIncl.
Average blood sugar over the past three months; diabetes.
Thyroid & Endocrine
TSHIncl.
Thyroid function; the primary thyroid screening test.
Vitamin D (25-OH)Incl.
Vitamin D deficiency; bone health.
Tumor Markers
AFPIncl.
Liver cancer marker (also used with liver ultrasound in hepatitis B carriers).
CA-125Incl.
Ovarian cancer marker.
CA 15-3Incl.
Breast cancer marker.
CA 19-9Incl.
Pancreatic and biliary cancer marker.
CEAIncl.
Colorectal and other GI cancer marker.
PSAIncl.
Prostate cancer marker.
Infection Serology
Hepatitis B surface antibodyIncl.
Immunity to hepatitis B (from vaccine or past infection).
Hepatitis C antibodyIncl.
Hepatitis C infection.
Hepatitis B surface antigenIncl.
Current hepatitis B infection; very common in Taiwan.
Cardiac
Resting ECGIncl.
Heart rhythm and signs of prior heart damage.
X-ray
Abdominal X-ray (KUB)Incl.
Kidney stones and bowel abnormalities.
Chest X-rayIncl.
Lung, heart size and chest abnormalities.
Ultrasound
Abdominal ultrasoundIncl.
Liver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.
Breast ultrasoundIncl.
Breast lumps; complements mammography, especially in dense breasts.
Pelvic (gynecologic) ultrasoundIncl.
Uterus and ovary abnormalities (fibroids, cysts).
Endoscopy
ColonoscopyIncl.
Colon polyps and colorectal cancer; polyps can usually be removed during the same exam.
Gastroscopy (upper GI endoscopy)Incl.
Stomach and esophagus ulcers, inflammation and cancer.
Women's Health
HPV DNA testIncl.
High-risk HPV strains that cause cervical cancer.
MammographyAdd-on
Breast cancer; the standard screen for women 40+.
Pap smearIncl.
Cervical cancer and precancer.
Bone & Body Composition
Bone density (DXA)Add-on
Osteoporosis and fracture risk.
ENT & Dental
ENT examinationIncl.
Ear, nose and throat abnormalities.
Also listed: Free T4, Hematocrit (HCT), High-sensitivity CRP, MCH (mean corpuscular hemoglobin), Preliminary body function assessment, Total protein (TP), Triglycerides (TG), Urine glucose, protein and blood screening.

Before you book

SedationAvailable
If something is foundAsk the hospital how any findings are explained, on the day or at a follow-up appointment; in Book it for me we ask for you and tell you before you book. Your own doctor decides what to do next; we do not arrange treatment.
Results and imagingAsk the hospital how long results take and how imaging is delivered; in Book it for me we ask for you and tell you before you book.
Shin Kong Wu Ho-Su Memorial Hospital Health Management Center
Medical center
Taipei · Shilin

About 9 minutes' walk (659 m) from Shilin station

On the OCAC i僑卡 partner list. Card holders can ask the center about a discount.

5 packages listed

About this hospital
US price context

Bought one by one at US cash-pay marketplaces, the tests we could price list at about US$6,596–9,560 for a woman (42 of 42 tests) and US$5,865–8,649 for a man (37 of 37 tests) (MDsave, Quest and others; checked 2026-10-11).

How we priced it

A panel counts once however many of its tests the package lists. A test for one sex only is counted only for that sex. Tests we could not price are left out, so this is not what a US checkup would cost. Prices marked "rough" come from a single reseller or are extrapolated from a similar test.

Radiation from this package's imaging

About 0.8 mSv from the tests we could identify, a typical adult dose for these exams: roughly 4 months of natural background radiation (about 3 mSv a year, US average).

This package also lists 8 items we have not matched to a test; if any of them is an X-ray, CT or PET scan, the total is higher.

  • Abdominal X-ray (KUB) · about 0.7 mSv
  • Chest X-ray · about 0.1 mSv

Optional add-ons would add: Bone density (DXA) (about less than 0.01 mSv), Mammography (about 0.28 mSv).

Typical doses from published references (RadiologyInfo.org ↗, Mettler et al. 2008 ↗); the actual dose depends on the scanner and protocol. Ask the center for its own figure.

What US screening guidelines say

The US Preventive Services Task Force is an independent US panel whose recommendations cover people without symptoms. Shown for comparison; it is not advice for you.

What US screening guidelines say about 21 of these tests
Hepatitis C antibody
Recommended (grade A/B)The USPSTF recommends screening all adults aged 18 to 79 years for hepatitis C virus infection. (2020) · USPSTF ↗
Blood pressure
Recommended (grade A/B)The USPSTF recommends screening for hypertension in adults 18 years or older with office blood pressure measurement, confirmed with measurement outside the clinical setting before starting treatment. (2021) · USPSTF ↗
Bone density (DXA)
Recommended (grade A/B)The USPSTF recommends screening for osteoporosis with bone density testing in postmenopausal women younger than 65 years who are at increased risk, based on a clinical risk-assessment tool. (2025) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for osteoporosis in men. (2025) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for osteoporosis with bone density testing in women 65 years or older. (2025) · USPSTF ↗
Breast ultrasound
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of supplemental screening with breast ultrasound in women found to have dense breasts on an otherwise negative screening mammogram. (2024) · USPSTF ↗ Note: Same I statement covers ultrasound and MRI as supplemental tests; see mri_breast. The USPSTF breast cancer screening statement does not apply to people at high risk of breast cancer (for example BRCA1/2 carriers or others with a high-risk genetic marker or syndrome, people who had high-dose chest radiation at a young age, or people with previous breast cancer or a high-risk breast lesion).
CA-125
Recommended against (grade D)The USPSTF recommends against screening for ovarian cancer in asymptomatic women, including with the CA-125 blood test. (2018) · USPSTF ↗ Note: Same D-grade recommendation covers CA-125 and transvaginal/pelvic ultrasound; see pelvic_ultrasound.
CA 19-9
Recommended against (grade D)The USPSTF recommends against screening for pancreatic cancer in asymptomatic average-risk adults. (2019) · USPSTF ↗ Note: The recommendation states there are currently no accurate, validated biomarkers for early detection of pancreatic cancer and that the USPSTF does not recommend screening the general population by any method; it does not name CA 19-9. The D grade applies to screening this population by any method, not to CA 19-9 as a separately graded test. It does not apply to people at high risk because of an inherited genetic syndrome or familial pancreatic cancer.
Colonoscopy
Recommended (grade A/B)The USPSTF recommends screening for colorectal cancer in adults aged 45 to 49 years, including with colonoscopy every 10 years. (2021) · USPSTF ↗ Note: Applies to asymptomatic adults at average risk of colorectal cancer: no prior colorectal cancer, adenomatous polyps or inflammatory bowel disease, and no personal diagnosis or family history of a known genetic disorder that carries a high lifetime risk, such as Lynch syndrome or familial adenomatous polyposis.
Recommended (grade A/B)The USPSTF recommends screening for colorectal cancer in all adults aged 50 to 75 years, including with colonoscopy every 10 years. (2021) · USPSTF ↗ Note: Applies to asymptomatic adults at average risk of colorectal cancer: no prior colorectal cancer, adenomatous polyps or inflammatory bowel disease, and no personal diagnosis or family history of a known genetic disorder that carries a high lifetime risk, such as Lynch syndrome or familial adenomatous polyposis.
Selective (grade C)The USPSTF recommends that clinicians selectively offer colorectal cancer screening, including with colonoscopy every 10 years, to adults aged 76 to 85 years based on overall health, prior screening history and the patient's preferences. (2021) · USPSTF ↗ Note: Grade C reflects an individual decision rather than a blanket recommendation for or against. Applies to asymptomatic adults at average risk of colorectal cancer: no prior colorectal cancer, adenomatous polyps or inflammatory bowel disease, and no personal diagnosis or family history of a known genetic disorder that carries a high lifetime risk, such as Lynch syndrome or familial adenomatous polyposis.
Fasting glucose
Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a fasting plasma glucose test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.
Hemoglobin A1c
Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a hemoglobin A1c test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.
Hepatitis B surface antigen
Recommended (grade A/B)The USPSTF recommends screening for hepatitis B virus infection, with an HBsAg test followed by confirmatory testing, in adolescents and adults at increased risk for infection. (2020) · USPSTF ↗ Note: Risk groups include people born in a country with HBV prevalence of 2% or more, US-born people not vaccinated as infants whose parents were born in regions with very high HBV prevalence (8% or more), people with HIV, people who inject drugs, men who have sex with men, and household or sexual contacts of someone with HBV. The recommendation names regions by prevalence, not countries.
HDL cholesterol
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Height, weight and BMI
Recommended (grade A/B)The USPSTF recommends that clinicians offer or refer adults with a body mass index of 30 or higher to intensive, multicomponent behavioral weight-loss interventions. (2018; an update is in progress) · USPSTF ↗ Note: The grade applies to offering or referring adults with a BMI of 30 or higher to intensive behavioral weight-loss programs, not to measuring height, weight or BMI; the USPSTF says screening for obesity is now part of routine clinical practice and was not a focus of its review. The USPSTF lists an update in progress, folded into a combined topic on healthy diet, physical activity and weight loss to prevent cardiovascular disease; the 2018 statement remains the current final recommendation as of 2026-09-25.
HPV DNA test
Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women younger than 21 years. (2018; an update is in progress) · USPSTF ↗ Note: The D statements are against cervical cancer screening in these groups by any test, including HPV testing; see the matching pap_smear rows.
Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women who have had a hysterectomy with removal of the cervix and do not have a history of a high-grade precancerous lesion (CIN 2 or 3) or cervical cancer. (2018; an update is in progress) · USPSTF ↗ Note: The D statements are against cervical cancer screening in these groups by any test, including HPV testing; see the matching pap_smear rows.
Recommended (grade A/B)The USPSTF recommends screening for cervical cancer in women aged 30 to 65 years with high-risk HPV testing every 5 years, alone or combined with cytology, as an alternative to cytology alone. (2018; an update is in progress) · USPSTF ↗ Note: For women aged 21 to 29 the 2018 statement recommends cytology alone every 3 years, not HPV testing. A draft update posted December 10, 2024 proposes primary HPV testing every 5 years (clinician- or patient-collected) for ages 30 to 65, with cytology every 3 years or cotesting every 5 years as alternatives; not yet a final USPSTF recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women older than 65 years who have had adequate prior negative screening and are not otherwise at high risk. (2018; an update is in progress) · USPSTF ↗ Note: The D statements are against cervical cancer screening in these groups by any test, including HPV testing; see the matching pap_smear rows.
Mammography
Recommended (grade A/B)The USPSTF recommends biennial screening mammography for women aged 40 to 74 years. (2024) · USPSTF ↗ Note: The USPSTF breast cancer screening statement does not apply to people at high risk of breast cancer (for example BRCA1/2 carriers or others with a high-risk genetic marker or syndrome, people who had high-dose chest radiation at a young age, or people with previous breast cancer or a high-risk breast lesion).
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening mammography in women 75 years or older. (2024) · USPSTF ↗ Note: The USPSTF breast cancer screening statement does not apply to people at high risk of breast cancer (for example BRCA1/2 carriers or others with a high-risk genetic marker or syndrome, people who had high-dose chest radiation at a young age, or people with previous breast cancer or a high-risk breast lesion).
Pap smear
Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women younger than 21 years. (2018; an update is in progress) · USPSTF ↗
Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women who have had a hysterectomy with removal of the cervix and do not have a history of a high-grade precancerous lesion (CIN 2 or 3) or cervical cancer. (2018; an update is in progress) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for cervical cancer every 3 years with cervical cytology alone in women aged 21 to 29 years. (2018; an update is in progress) · USPSTF ↗ Note: A draft update was posted December 10, 2024 (public comment to January 13, 2025); not yet a new final recommendation as of 2026-09-25.
Recommended (grade A/B)The USPSTF recommends screening for cervical cancer in women aged 30 to 65 years, every 3 years with cytology alone, every 5 years with high-risk HPV testing alone, or every 5 years with HPV testing combined with cytology. (2018; an update is in progress) · USPSTF ↗ Note: A draft update was posted December 10, 2024 (public comment to January 13, 2025); not yet a new final recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women older than 65 years who have had adequate prior negative screening and are not otherwise at high risk. (2018; an update is in progress) · USPSTF ↗
Pelvic (gynecologic) ultrasound
Recommended against (grade D)The USPSTF recommends against screening for ovarian cancer in asymptomatic women, including with transvaginal ultrasound. (2018) · USPSTF ↗ Note: Same D-grade recommendation covers pelvic/transvaginal ultrasound and the CA-125 blood test; see ca125. This csv does not map pelvic_ultrasound to any recommendation about non-ovarian pelvic findings (fibroids, cysts), which the USPSTF does not address.
PSA
Selective (grade C)The USPSTF says the decision to undergo periodic PSA-based screening for prostate cancer should be an individual one for men aged 55 to 69 years. (2018; an update is in progress) · USPSTF ↗ Note: The USPSTF lists an update of this topic as in progress; the 2018 statement remains the current final recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against PSA-based screening for prostate cancer in men 70 years or older. (2018; an update is in progress) · USPSTF ↗ Note: The USPSTF lists an update of this topic as in progress; the 2018 statement remains the current final recommendation as of 2026-09-25.
Resting ECG
Recommended against (grade D)The USPSTF recommends against screening with resting or exercise ECG to prevent cardiovascular disease events in asymptomatic adults at low risk of CVD events. (2018) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening with resting or exercise ECG to prevent cardiovascular disease events in adults at intermediate or high risk of CVD events. (2018) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for atrial fibrillation with ECG in adults 50 years or older. (2022) · USPSTF ↗
Total cholesterol
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
TSH
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults. (2015) · USPSTF ↗ Note: The I statement concerns screening for thyroid dysfunction, for which the USPSTF names serum TSH as the primary screening test; T4 is described as follow-up testing after a persistently abnormal TSH.
Vitamin D (25-OH)
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for vitamin D deficiency in asymptomatic adults. (2021) · USPSTF ↗
General preparation notes for 11 tests in this package

This is general information about how the exam is usually done, not medical advice for you or your family member. Requirements vary by center and by individual health history — always follow the center's own instructions and your own doctor's guidance, especially for any medicine change.

Total cholesterol

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested, so the test is often done in the morning.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Fasting glucose

Usually needs at least 8 hours without food or drink except water beforehand.

Mention when booking: If you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting, and mention it to the center.

Chest X-ray

Usually needs no fasting; you remove jewelry, metal objects and sometimes clothing above the waist for a hospital gown.

Mention when booking: Tell the center if you are, or might be, pregnant.

Abdominal ultrasound

Usually needs about 6 hours without food beforehand; clear fluids other than milk or fizzy drinks are commonly still allowed. Loose, comfortable clothing is easiest.

Mention when booking: Mention if you have type 1 diabetes, so the center can offer an early appointment time.

Pelvic (gynecologic) ultrasound

For a transabdominal scan, drinking water beforehand to fill the bladder is common; for a transvaginal scan, an empty bladder is usual instead.

Mention when booking: Tell the center which type of scan you expect, and mention if you are, or might be, pregnant.

Colonoscopy

Usually needs a clear-liquid diet the day before and a split-dose bowel-cleansing prep taken the evening before and morning of the exam; drinking extra fluids helps avoid dehydration.

Mention when booking: Tell the center about heart, kidney or lung disease, blood thinners, diabetes medicine, aspirin, arthritis medicine or iron; ask the prescribing doctor before changing any medicine.

Afterwards: After sedation, no driving, operating machinery or signing legal documents for the rest of the day; someone should take you home.

Gastroscopy (upper GI endoscopy)

Usually needs about 8 hours without food or drink, including water, beforehand.

Mention when booking: Tell the center about heart or lung disease, aspirin, blood thinners, arthritis medicine, insulin or iron, and ask the prescribing doctor before changing any medicine.

Afterwards: After sedation, no driving, machinery or legal documents that day; get a ride home. Contact a doctor for fever, trouble swallowing, chest or belly pain, or black stools; bleeding can start days later.

HPV DNA test

Usually needs no special preparation; if combined with a Pap test, avoiding sex, douching and vaginal products for 2 days beforehand is common.

Mention when booking: Tell the center if you are menstruating or had recent intercourse; the test can usually still be done.

Afterwards: Light spotting afterward is common and usually stops within a few hours.

Pap smear

Usually asks that you avoid intercourse, douching and tampons for 24 hours beforehand, and avoid scheduling during your period if possible.

Mention when booking: Tell the center if you are having unexpected bleeding, think you might be pregnant, or have had an abnormal Pap or positive HPV test before.

Afterwards: Light bleeding or spotting afterward is common and usually stops within a few hours.

Mammography

Usually asks that you skip deodorant, powder or lotion on the underarms and breasts, since these can look like calcium spots on the image. Bring prior mammograms from elsewhere if you have them.

Mention when booking: Mention breast implants, any breast symptoms, prior breast surgery, hormone use, or the possibility of pregnancy.

Afterwards: You may be asked to wait until the radiologist confirms the images are complete; ask when to expect results.

Bone density (DXA)

Usually asks that you skip calcium supplements for 24 hours beforehand. Avoid clothing with metal zippers or buttons, and remove jewelry.

Mention when booking: Mention any recent barium exam or CT/nuclear-medicine contrast, and whether pregnancy is possible.

Sources
As published by the hospital · checked 2026-09-22

How we collect and check these prices: see who we are and where the data comes from.

US$ at 32.1 TWD, 23 Sep 2026; you pay in NT$.
Package name translated by us from the hospital's Chinese name.
Women's Checkup
US$1,016
Book this checkup

If this isn't quite right

Same hospital, cheaper
Deluxe Checkup + LD-CT
Shin Kong Wu Ho-Su Memorial Hospital Health Management Center
US$997
Same hospital, adds Low-dose chest CT
Women's Checkup + LD-CT
Shin Kong Wu Ho-Su Memorial Hospital Health Management Center
US$1,146
Same focus, Pingtung
VIP CT Package
Pingtung Hospital, Ministry of Health and Welfare
US$997

Other packages at Shin Kong Wu Ho-Su Memorial Hospital

PackageTestsPrice
MRI Scanning for Cerebrovascular Check-up27
US$841
NT$27,000
Deluxe Checkup50
US$866
NT$27,800
Deluxe Checkup + LD-CT50
US$997
NT$32,000
Women's Checkup + LD-CT53
US$1,146
NT$36,800

All packages at Shin Kong Wu Ho-Su Memorial Hospital Health Management Center →

Similar packages in Taipei

Same tier, other hospitals in Taipei, closest in price first.
PackageHospitalTestsPrice
Elite General Checkup PackageCheng Hsin General Hospital Health Management Center84
US$935
NT$30,000
Women US$997
+20% without Taiwan ID or NHI card
Advanced MRI Whole-Body Health Checkup - Plan AChung Shan Hospital (Taipei)55
US$935
NT$30,000
Advanced MRI Whole-Body Health Checkup - Plan BChung Shan Hospital (Taipei)55
US$1,121
NT$36,000
Deluxe Elite PackageChang Gung Memorial Hospital Taipei Health Examination Center83
US$1,153
NT$37,000
Women US$1,246
IMS-2 CheckupMackay Memorial Hospital Health Examination Center48
US$872
NT$28,000
Standard Cancer Prevention PackageNational Taiwan University Cancer Center61
US$869
NT$27,900
Women US$981

All checkups in Taipei →

US$ at 32.1 TWD, 23 Sep 2026; you pay in NT$.

Browse: Cancer screening · Stomach and colon · Women's health · All checkups in Taipei · What a checkup costs in Taiwan